Wednesday, January 13, 2016

Actively targeted gold nanoparticles as novel radiosensitizer agents: an in vivo head and neck cancer model

Nanoscale, 2016, Advance Article
DOI: 10.1039/C5NR07496G, Paper
Aron Popovtzer, Aviram Mizrachi, Menachem Motiei, Dimitri Bragilovski, Leon Lubimov, Mattan Levi, Ohad Hilly, Irit Ben-Aharon, Rachela Popovtzer
A major problem in the treatment of head and neck cancer today is the resistance of tumors to traditional radiation therapy, which results in 40% local failure, despite aggressive treatment.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment